Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
What is your approach to a patient with incidentally found DCIS or invasive disease after a breast reduction?
Generally, the margins are uncertain in this scenario and re-excision is usually not possible.
Answer from: Radiation Oncologist at Community Practice
Typically, in these cases I will give standard whole breast irradiation (40/15). I have not boosted as it's often unclear where the boost target is.
Comments
Radiation Oncologist at Blanchard Valley Hospital
Thank you - how do you address the axilla in cases...
Radiation Oncologist at Allegheny Health Network, Pittsburgh
For DCIS, don't routinely push for SLN. For invasi...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Sometimes for these small incidentally diagnosed l...
Radiation Oncologist at Naval Medical Center San Diego
I have a male patient in his 20s with bilateral G1...
Radiation Oncologist at Allegheny Health Network, Pittsburgh
I would wait for genetics; if BRCA mutation, would...
Radiation Oncologist at Naval Medical Center San Diego
Margins negative but close <1 mm bilaterally (n...
Radiation Oncologist at Allegheny Health Network, Pittsburgh
I would think so, there is not a lot of data on th...
Radiation Oncologist at Naval Medical Center San Diego
Thanks!
2341
2343
2344
13755
13760
13761
13771
13774
Sign in or Register to read more
6764
Related Questions
How do you choose between ALND and RNI in the setting of LYMPHA or S-Lympha surgery?
Are there additional risks associated with PMRT for a patient with prior lympho-venous bypass surgery?
In a patient with cardiac comorbidities, who meets ASTRO APBI criteria other than a positive margin, would you offer APBI in an attempt to reduce cardiac dose?
Do you start systemic therapy for patients with previously localized HR+ breast cancer developing solitary bone metastasis which is now triple negative if there are no other sites of disease after metastasis-directed radiation?
What are the advantages/disadvantages of using static IMRT vs VMAT when treating breast cancer?
Do you recommend adjuvant RT to patients with non-ATM genetic mutations (e.g. BRCA, NF) who elect to have lumpectomy and are otherwise PRIME II/CALGB candidates for RT omission (i.e. low risk disease characteristics: strongly ER+, <1cm, grade 1-2, no LVI, widely negative margins, and committed to endocrine therapy)?
If a patient has multiple PET-avid level 3, supraclavicular, or IMN nodes that are small and would have been considered negative by size criteria with traditional imaging, that are no longer positive on PET after chemotherapy, would you try to boost these nodes?
Would you recommend PMRT in a patient with a triple negative cT2N0, ypT2N0 metaplastic breast cancer s/p NAC, mastectomy, and SLNB?
Can a patient receiving post-mastectomy radiation therapy be treated concurrently with total body UVA or UVB light therapy for psoriasis?
What is your preferred method of surveillance after mastectomy?
Thank you - how do you address the axilla in cases...
For DCIS, don't routinely push for SLN. For invasi...
Sometimes for these small incidentally diagnosed l...
I have a male patient in his 20s with bilateral G1...
I would wait for genetics; if BRCA mutation, would...
Margins negative but close <1 mm bilaterally (n...
I would think so, there is not a lot of data on th...
Thanks!